However, on the other hand, inhibiting USP22 in turn would increase proportions of NK cells and CD8 + T cells, and destroy the fitness of Tregs, making ‘cold’ tumors into ‘hot’ tumors, thereby converting tumor cells that are fully resistant to ICIs immunotherapy to a sensitive state [100]. Here, USP22 is linked to neoplasm.